Related Experiment Videos
Anti-hypercholesterolemic effect of melatonin in rats
1Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
Acta Pathologica Japonica
|October 1, 1989
Summary
Melatonin administration did not affect plasma lipids in rats on a normal diet. However, it blunted the negative effects of a high-cholesterol diet on plasma lipids and reduced liver fatty infiltration.
Area of Science:
- Biochemistry
- Endocrinology
- Nutritional Science
Background:
- High-cholesterol diets can lead to adverse plasma lipid profiles and liver conditions.
- Melatonin, a hormone, is being investigated for its potential health effects.
Purpose of the Study:
- To investigate the impact of melatonin on plasma lipids and liver morphology in rats fed high-cholesterol diets.
- To determine if melatonin influences lipid metabolism and lipoprotein levels.
Main Methods:
- Rats were administered daily intraperitoneal injections of melatonin (4 mg) for 10-27 days.
- Biochemical and morphological analyses were performed on plasma lipids and liver tissues.
- Animals were fed either a regular or a high-cholesterol (1% cholesterol, 0.5% cholic acid) diet.
Main Results:
- Melatonin did not significantly alter plasma lipids in rats on a normal diet.
- In rats on a high-cholesterol diet, melatonin blunted increases in VLDL and LDL cholesterol and protein, and decreases in HDL cholesterol and protein.
- Melatonin reduced fatty infiltration in the liver of rats fed a high-cholesterol diet.
- No significant effects of melatonin on lipase activity were observed.
Conclusions:
- Melatonin exhibits a protective, quantitative effect against diet-induced dyslipidemia.
- Melatonin may mitigate the adverse effects of high-cholesterol diets on plasma lipoproteins and liver health.
- Further research is warranted to explore the therapeutic potential of melatonin in lipid management.